Comparing benefits and risks of immunization
- PMID: 11496624
- PMCID: PMC6979848
- DOI: 10.1007/BF03404299
Comparing benefits and risks of immunization
Abstract
Background: This paper uses a straightforward method of quantifying the benefits and risks of immunization, illustrated by universal immunization programs in British Columbia against invasive Haemophilus influenzae type b disease (Hib), measles, rubella, and paralytic poliomyelitis.
Methods: Data were extracted from provincial communicable disease and vaccine adverse event surveillance systems. Average disease incidence was compared before and after implementing universal immunization programs. Estimates of prevented deaths and serious disease complications were calculated and compared with expected numbers of serious vaccine-associated adverse events (VAAEs).
Results: Average incidence of reported cases decreased 90 to 100% over a 5-year period after implementing universal programs. These benefits were sustained or strengthened over time. Rates of reported serious VAAEs were low.
Discussion: The remarkable success of immunization has created a paradox. Despite a low absolute risk of serious VAAEs, the relative risk of some VAAEs can exceed risk of disease in the province.
Contexte: L’étude emploie une méthode simple pour quantifier les avantages et les risques de l’immunisation, tels qu’illustrés par les programmes de vaccination systématiques de la Colombie-Britannique contre l’infection invasive à HiB (hémophilus influenzae B), la rougeole, la rubéole et la poliomyélite paralytique.
Méthode: Nous avons extrait des données des systèmes provinciaux de surveillance des maladies transmissibles et des réactions adverses aux vaccins, puis comparé l’incidence moyenne des maladies avant et après la mise en oeuvre de programmes de vaccination systématiques. Nous avons ensuite estimé les décès et les complications graves évités, que nous avons comparés avec le nombre attendu de réactions adverses vaccinales (RAV) graves.
Résultats: L’incidence moyenne de cas déclarés a diminué dans une proportion de 90 à 100 % sur cinq ans après la mise en oeuvre des programmes systématiques. Ces avantages se sont maintenus ou renforcés avec le temps. Les taux déclarés de RAV graves étaient faibles.
Question à débattre: Le succès remarquable de la vaccination entraîne un paradoxe: bien que le risque absolu de RAV grave soit faible, le risque relatif de certaines RAV peut dépasser le risque de la maladie dans la province.
Similar articles
-
Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44. doi: 10.1001/archpedi.159.12.1136. Arch Pediatr Adolesc Med. 2005. PMID: 16330737
-
Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative.MMWR Morb Mortal Wkly Rep. 1994 Feb 4;43(4):57-60. MMWR Morb Mortal Wkly Rep. 1994. PMID: 8295625
-
A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.Vaccine. 2018 Sep 11;36(38):5678-5684. doi: 10.1016/j.vaccine.2018.08.029. Epub 2018 Aug 16. Vaccine. 2018. PMID: 30122645
-
Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication.Expert Rev Vaccines. 2020 Oct;19(10):903-917. doi: 10.1080/14760584.2020.1825948. Epub 2020 Oct 10. Expert Rev Vaccines. 2020. PMID: 32962476 Review.
-
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.Lancet. 2009 Sep 12;374(9693):903-11. doi: 10.1016/S0140-6736(09)61203-4. Lancet. 2009. PMID: 19748399 Review.
Cited by
-
Addressing heterogeneous parental concerns about vaccination with a multiple-source model: a parent and educator perspective.Hum Vaccin Immunother. 2013 Aug;9(8):1790-4. doi: 10.4161/hv.24888. Epub 2013 May 31. Hum Vaccin Immunother. 2013. PMID: 23732902 Free PMC article. Review.
References
-
- Pless R. Do vaccines cause chronic illness?: Assessing and responding to unconfirmed allegations. Update: Vaccine-Preventable Diseases. 1998;6(2):15–16.
-
- Canadian Paediatric Society. Your Child’s Best Shot. Ottawa: Canadian Paediatric Society; 1997.
-
- Six Common Misconceptions about Vaccination. www.cdc.gov/nip/publications/6mishome.htm. Accessed 6 July 2000.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical